These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 7673409

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors.
    Arnaldi G, Gasc JM, de Keyzer Y, Raffin-Sanson ML, Perraudin V, Kuhn JM, Raux-Demay MC, Luton JP, Clauser E, Bertagna X.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2029-35. PubMed ID: 9626135
    [Abstract] [Full Text] [Related]

  • 3. Effects of serotonin and vasopressin on cortisol production from an adrenocortical tumor causing subclinical Cushing's syndrome.
    Contesse V, Reznik Y, Duparc C, Perraudin V, Vaudry H, Kuhn JM, Lefebvre H.
    Endocr Res; 2002 Nov; 28(4):787-91. PubMed ID: 12530699
    [Abstract] [Full Text] [Related]

  • 4. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
    Tatsuno I, Uchida D, Tanaka T, Koide H, Shigeta A, Ichikawa T, Sasano H, Saito Y.
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
    [Abstract] [Full Text] [Related]

  • 5. Aberrant adrenal sensitivity to vasopressin in adrenal tumours associated with subclinical or overt autonomous hypercortisolism: is this explained by an overexpression of vasopressin receptors?
    Joubert M, Louiset E, Rego JL, Contesse V, Kong LC, Benhaim A, Mittre H, Lefebvre H, Reznik Y, REHOS Study Group.
    Clin Endocrinol (Oxf); 2008 May; 68(5):692-9. PubMed ID: 17980016
    [Abstract] [Full Text] [Related]

  • 6. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension.
    Lacroix A, Tremblay J, Touyz RM, Deng LY, Lariviere R, Cusson JR, Schiffrin EL, Hamet P.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2414-22. PubMed ID: 9253310
    [Abstract] [Full Text] [Related]

  • 7. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies.
    Tsagarakis S, Tsigos C, Vassiliou V, Tsiotra P, Pratsinis H, Kletsas D, Trivizas P, Nikou A, Mavromatis T, Sotsiou F, Raptis S, Thalassinos N.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):583-9. PubMed ID: 11158012
    [Abstract] [Full Text] [Related]

  • 8. Vasopressin receptors modulate the pharmacological phenotypes of Cushing's syndrome.
    Arnaldi G, de Keyzer Y, Gasc JM, Clauser E, Bertagna X.
    Endocr Res; 1998 Feb; 24(3-4):807-16. PubMed ID: 9888581
    [Abstract] [Full Text] [Related]

  • 9. In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia.
    Daidoh H, Morita H, Hanafusa J, Mune T, Murase H, Sato M, Shibata T, Suwa T, Ishizuka T, Yasuda K.
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):403-9. PubMed ID: 9861334
    [Abstract] [Full Text] [Related]

  • 10. Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of V1 receptors.
    Perraudin V, Delarue C, Lefebvre H, Contesse V, Kuhn JM, Vaudry H.
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1522-8. PubMed ID: 7684742
    [Abstract] [Full Text] [Related]

  • 11. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 12. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G, DeBold CR, Gaitan D, DeCherney GS, Jackson RV, Sheldon WR, Nicholson WE, Orth DN.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [Abstract] [Full Text] [Related]

  • 13. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Horiba N, Suda T, Aiba M, Naruse M, Nomura K, Imamura M, Demura H.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
    [Abstract] [Full Text] [Related]

  • 14. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism.
    Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, Emy P, Bertagna X, Kuhn JM, Vaudry H, Lefebvre H.
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1302-10. PubMed ID: 15585558
    [Abstract] [Full Text] [Related]

  • 15. Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome.
    de Groot JW, Links TP, Themmen AP, Looijenga LH, de Krijger RR, van Koetsveld PM, Hofland J, van den Berg G, Hofland LJ, Feelders RA.
    Eur J Endocrinol; 2010 Aug; 163(2):293-9. PubMed ID: 20460422
    [Abstract] [Full Text] [Related]

  • 16. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates.
    Louiset E, Contesse V, Groussin L, Cartier D, Duparc C, Perraudin V, Bertherat J, Lefebvre H.
    J Endocrinol; 2008 Jan; 196(1):1-9. PubMed ID: 18180312
    [Abstract] [Full Text] [Related]

  • 17. Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis.
    Chabre O, Liakos P, Vivier J, Chaffanjon P, Labat-Moleur F, Martinie M, Bottari SP, Bachelot I, Chambaz EM, Defaye G, Feige JJ.
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3134-43. PubMed ID: 9745416
    [Abstract] [Full Text] [Related]

  • 18. The human homolog of Diminuto/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene overexpressed in benign cortisol-producing adrenocortical adenomas.
    Sarkar D, Imai T, Kambe F, Shibata A, Ohmori S, Siddiq A, Hayasaka S, Funahashi H, Seo H.
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5130-7. PubMed ID: 11701665
    [Abstract] [Full Text] [Related]

  • 19. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Mune T, Murase H, Yamakita N, Fukuda T, Murayama M, Miura A, Suwa T, Hanafusa J, Daido H, Morita H, Yasuda K.
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5706-13. PubMed ID: 12466375
    [Abstract] [Full Text] [Related]

  • 20. [Membrane receptors and endocrine tumors: expression of vasopressin receptor V1 modulates the pharmacologic phenotype of adrenocortical tumors].
    Luton JP, Bertagna X.
    Bull Acad Natl Med; 1998 Dec; 182(2):299-309; discussion 309-10. PubMed ID: 9648345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.